
Sign up to save your podcasts
Or


STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
By STAT4.5
320320 ratings
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.

1,992 Listeners

753 Listeners

1,109 Listeners

821 Listeners

497 Listeners

127 Listeners

6,101 Listeners

62 Listeners

87 Listeners

35 Listeners

5,595 Listeners

55 Listeners

21 Listeners

398 Listeners

15 Listeners

12 Listeners